|
G3BP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.47215573065296E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62636570877339E-12 |
| Normal-vs-Stage2 |
4.42430000000549E-05 |
| Normal-vs-Stage3 |
6.680100E-03 |
| Normal-vs-Stage4 |
4.815800E-01 |
| Stage1-vs-Stage2 |
4.565000E-01 |
| Stage1-vs-Stage3 |
1.683590E-03 |
| Stage1-vs-Stage4 |
1.164210E-01 |
| Stage2-vs-Stage3 |
1.380190E-01 |
| Stage2-vs-Stage4 |
2.098000E-01 |
| Stage3-vs-Stage4 |
5.503400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.17523785042795E-14 |
| Normal-vs-AfricanAmerican |
2.69669842012377E-11 |
| Normal-vs-Asian |
4.052800E-01 |
| Caucasian-vs-AfricanAmerican |
7.463400E-01 |
| Caucasian-vs-Asian |
1.169610E-01 |
| AfricanAmerican-vs-Asian |
1.283990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62803104331033E-12 |
| Normal-vs-Female |
2.87219999994814E-06 |
| Male-vs-Female |
7.011200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.76809999999461E-06 |
| Normal-vs-Extreme_Weight |
1.62769797640294E-12 |
| Normal-vs-Obese |
2.59949994863007E-09 |
| Normal-vs-Extreme_Obese |
7.29050000369824E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.797430E-01 |
| Normal_Weight-vs-Obese |
9.282200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.633600E-01 |
| Extreme_Weight-vs-Obese |
4.807800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.410800E-01 |
| Obese-vs-Extreme_Obese |
3.227000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.239500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.14949946730769E-10 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
1.51350043609E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.187400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.307800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.743700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.735300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.622600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.124800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62470037423645E-12 |
| Normal-VS-Type2 PRCC |
1.37609999995014E-06 |
| Normal-VS-KIRP CIMP |
1.622790E-01 |
| Normal-VS-Unclassified PRCC |
1.13440000004683E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.700900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.21989999999295E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.874040E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.474000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.746400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.653600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.40110178803843E-11 |
| Normal-vs-N1 |
2.899400E-01 |
| Normal-vs-N2 |
1.793600E-01 |
| N0-vs-N1 |
3.904900E-03 |
| N0-vs-N2 |
5.965000E-01 |
| N1-vs-N2 |
3.487800E-01 |
|
|
